St. Jude’s ICDs, CRT-Ds get CE mark

Candace Stuart | May 13, 2013 | Cardiovascular Business | Heart Rhythm

The Ellipse and Assura portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds) received CE mark in Europe, St. Jude Medical announced.

The devices include an algorithm that adjusts shocking configurations within the device to ensure the delivery of high-voltage therapy in the event of an electrical short in one portion of the system. Another algorithm is designed to reduce the risk of inappropriate shocks by differentiating lead noise (over-sensing of electrical signals) from true ventricular tachycardia or ventricular fibrillation episodes requiring therapy.

In addition, the defibrillators feature coating on the device can that has been shown to significantly reduce friction between the device and leads that potentially can cause lead-to-can abrasion.

St. Jude Medical is based in St. Paul, Minn.

Candace Stuart, Contributor

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

St. Jude’s ICDs, CRT-Ds get CE mark

Related Content

Around the web